Cargando…
Development of a liver‐specific Tet‐off AAV8 vector for improved safety of insulin gene therapy for diabetes
BACKGROUND: Diabetes mellitus is caused by a partial or complete lack of insulin production in the body. We have previously shown that a single injection of an adeno‐associated virus serotype 8 (AAV8) vector carrying a modified and codon optimized human insulin gene induced hepatic production of ins...
Autores principales: | Gan, Shu Uin, Fu, Zhenying, Sia, Kian Chuan, Kon, Oi Lian, Calne, Roy, Lee, Kok Onn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590178/ https://www.ncbi.nlm.nih.gov/pubmed/30592790 http://dx.doi.org/10.1002/jgm.3067 |
Ejemplares similares
-
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice
por: Recino, Asha, et al.
Publicado: (2018) -
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice
por: Sia, Kian Chuan, et al.
Publicado: (2020) -
Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors
por: Han, Ye, et al.
Publicado: (2010) -
First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model
por: Sia, Kian Chuan, et al.
Publicado: (2022) -
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)